BlackRock
IMI

BlackRock’s Intermolecular, Inc. IMI Stock Holding History

BlackRock’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-135,051
Closed -$158K – 5143
2019
Q2 		$158K Buy
135,051
+11,907
+10% +$13.7K ﹤0.01% 4401
2019
Q1 		$142K Sell
123,144
-1,839
-1% -$2.01K ﹤0.01% 4315
2018
Q4 		$126K Buy
124,983
+807
+0.6% +$810 ﹤0.01% 4314
2018
Q3 		$146K Buy
124,176
+2,550
+2% +$3.65K ﹤0.01% 4388
2018
Q2 		$203K Buy
121,626
+50,101
+70% +$68.3K ﹤0.01% 4300
2018
Q1 		$94K Buy
71,525
+504
+0.7% +$718 ﹤0.01% 4351
2017
Q4 		$98K Buy
71,021
+708
+1% +$852 ﹤0.01% 4337
2017
Q3 		$72K Sell
70,313
-16,368
-19% -$15.4K ﹤0.01% 4420
2017
Q2 		$78K Sell
86,681
-45,964
-35% -$40.2K ﹤0.01% 4448
2017
Q1 		$123K Buy
+132,645
New +$138K ﹤0.01% 4300

BlackRock's IMI Position: Q3 2019 in Review

BlackRock sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 135,051 shares — an estimated $158K sold.

BlackRock first reported a position in IMI in Q1 2017 and held it in 10 quarters. The position peaked at $203K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.

  • BlackRock reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
  • BlackRock sold 135,051 Intermolecular, Inc. shares in Q3 2019, an estimated $158K.
  • BlackRock first reported a position in Intermolecular, Inc. in Q1 2017 and held it in 10 quarters.
  • BlackRock's Intermolecular, Inc. position peaked at $203K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.

Based on BlackRock's 13F filing for Q3 2019, filed 8 Nov 2019.